Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
397
NCT06058962
Double Blind Trial in Children With Autism Spectrum Disorder
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 1, 2019
Completion: Mar 15, 2021
NCT06060600
A Retrospective Analysis of Suramin Treatment for Stage 1 TBR
Phase: N/A
Start: Jan 2, 2023
Completion: Aug 2, 2023